share_log

Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

SEC ·  Mar 11 12:51
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 310

Recommended